📋 Workflow
Full workflow, products add-to-cart directly1
Literature and expression verification
1–2 daysSearch literature and measure target expression in disease cells/tissues
💡 Tip Aberrant expression suggests involvement
⚠️ Caution Compare with multiple tissues/controls
🧪 Materials for this step (click to shop by spec/brand)
2
Functional manipulation
1–2 weeksKnock down/out with siRNA/CRISPR, or modulate with overexpression and inhibitors
💡 Tip Cross-validate with multiple approaches
⚠️ Caution Verify knockdown efficiency/specificity
🧪 Materials for this step (click to shop by spec/brand)
3
Phenotype and downstream readout
1 weekMeasure proliferation, apoptosis, migration and downstream signaling changes
💡 Tip Choose disease-relevant biological endpoints
⚠️ Caution Exclude off-target effects
🧪 Materials for this step (click to shop by spec/brand)
4
Integrate and conclude
1–2 daysIntegrate evidence to judge target relevance/druggability and form a validation report
💡 Tip Strong validation needs both mechanistic and phenotypic evidence
⚠️ Caution Conclude cautiously
🧪 Materials for this step (click to shop by spec/brand)
⚠️ 5 Common Beginner Mistakes
- ① Incomplete knockdown gives no phenotype
- ② Off-target/compensation confounds results
- ③ Expression level alone doesn't prove function
- ④ Single-method evidence over-interpreted
- ⑤ Missing functional/mechanistic endpoints
❓ FAQ
+How to judge druggability?
Assess structural binding site, modulatability, in vivo accessibility and safety signals.
+Knockout vs knockdown?
Knockout gives strong phenotype but may be lethal/compensatory; knockdown is dose-controllable and mimics drug.
+What is mechanistic validation?
Confirming target modulation causes consistent downstream pathway/phenotype changes, building causality.